Developer docs
API playgroundTry for free, no card

Search company profiles

4G Clinical

Full company profile

uuid0000qoi

Namestring
4G Clinical
Legal namestring
4G Clinical
Websiteurl
4gclinical.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

4G Clinical is a Wellesley, Massachusetts-based software company that provides randomization and trial supply management (RTSM) technology for clinical drug trials. Its core platform, Prancer RTSM®, unifies randomization, supply management, and study oversight in a single operational environment, keeping patient dosing, supply movement, and forecasting connected to real-time study activity. The product suite is complemented by 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial requirements, Ultima Rand® for randomization, and the Enterprise Prancer Integrations (EPI) framework for sponsor-level program governance. The company serves over 100 biotech and pharma clients globally, with horizontal segmentation across small and mid-size biotechs, contract research organizations (CROs), and large enterprise pharmaceutical companies.

4G Clinical operates a subscription-based enterprise SaaS model on multi-year contracts, with quote-based pricing and dedicated delivery specialists engaged from study kickoff through closeout. Go-to-market is direct enterprise sales supported by content marketing (blog, white papers, podcasts, webinars), industry events, and LinkedIn presence. The company holds filed/pending patents related to clinical trial randomization and supply management technology and markets itself on operational continuity, governed amendment pathways, and supply forecasting matched to protocol design.

The company was co-founded by David Kelleher (CEO) and Ed Tourtellotte (Board Director). In mid-2021, it closed a $230 million growth equity investment from Goldman Sachs Asset Management to fund global expansion, product development, and team growth. In August 2024, Dr. Ronan Brown was appointed as Chief Operating Officer, indicating continued organizational scaling. Headcount sits in the 251–500 range, and the company claims global delivery across multiple countries.

Short descriptiontext

4G Clinical provides subscription-based randomization and trial supply management (RTSM) software, anchored by its Prancer RTSM® platform. It serves more than 100 biotech and pharma clients globally, including biotechs, CROs, and large pharmaceutical companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersWellesley, United States
HQ citystring
Wellesley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
randomization and trial supply management, clinical trial software, RTSM solutions, clinical supply forecasting, trial supply optimization
Industry2 codes
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Software (RTSM)
Revenue model1 record
1Software Subscription (RTSM)
TypeSubscription Recurring
Description

SaaS-based randomization and trial supply management software delivered as subscription service with dedicated delivery and specialist support throughout the study lifecycle.

4gclinical.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise RTSM solutions with dedicated support
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based pricing; demos available to discuss specific functionality and organizational needs.

4gclinical.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1Prancer RTSM®
Description

Flexible Randomization and Trial Supply Management solution that unifies randomization, supply management, and study oversight for more aligned trial execution.

4gclinical.com
+4 more records
Core offering1 text field

4G Clinical sells cloud-based Randomization and Trial Supply Management (RTSM) software, led by its Prancer RTSM® platform that unifies randomization, supply management, and study oversight for live clinical trial execution. The company complements this with 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial designs, EPI integration framework, and Ultima Rand® randomization technology, all delivered as a SaaS subscription with dedicated specialist teams supporting biotech, CRO, and pharma customers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Supports clinical trials across multiple countries with global delivery experience
+1 more record
Product overview1 text field

4G Clinical delivers randomization and trial supply technology built for complex clinical trials. The core offering is Prancer RTSM®, which unifies randomization, supply management, and study oversight within a single operational environment. This is complemented by 4C Supply® for broader forecasting, scenario modelling, and long-range planning, as well as Prancer Lite® for studies with more streamlined requirements. Enterprise Prancer Integrations (EPI) provide a connectivity framework for scalable deployment across programs. The product suite supports over 100 biotech and pharma clients in global clinical trials.

Product and service4 records
1Prancer RTSM®
CategoryClinical Trial Software (RTSM)
Description

Cloud-based Randomization and Trial Supply Management (RTSM) platform that unifies randomization, supply, and forecasting for live clinical trial execution. It keeps patient dosing, supply movement, and oversight connected to real-time study activity for biotechs, CROs, and large pharma sponsors.

24C Supply®
CategoryClinical Trial Software (Supply Forecasting)
Description

Forecasting, scenario modeling, and supply oversight solution aligned to changing study demand, supporting min/max models through predictive and dynamic demand forecasting for clinical trial supply chains.

3Prancer Lite®
CategoryClinical Trial Software (RTSM)
Description

Lighter, simplified version of the Prancer RTSM platform for clinical studies with more streamlined randomization and supply requirements, typically used by smaller biotechs.

4Ultima Rand®
CategoryClinical Trial Software (Randomization)
Description

Supporting randomization technology that powers randomization capabilities within 4G Clinical's product ecosystem.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Suvoda is a purpose-built IRT/RTSM specialist serving biotech and pharma sponsors with similar randomization, supply management, and eClinical workflows. It is the closest direct competitor to 4G Clinical's Prancer RTSM offering.

TypeDirect peer
Description

Endpoint Clinical (now part of the Clinical ink / broader portfolio) specializes in RTSM/IRT and interactive response technology for clinical trials. It targets similar biotech and pharma customers with comparable randomization and drug supply management functionality.

TypeBroad incumbent
Description

Medidata (a Dassault Systèmes company) offers Rave RTSM as part of its industry-leading unified clinical trial platform spanning EDC, eCOA, and CTMS. It is a broad incumbent with deep enterprise pharma penetration and a major competitive force for 4G Clinical.

TypeDirect peer
Description

Signant Health provides RTSM alongside eCOA, eConsent, and patient engagement solutions for clinical trials. It directly competes with 4G Clinical in the randomization and trial supply management category, serving overlapping biotech and pharma customers.

TypeDirect peer
Description

Clario delivers RTSM/IRT, eCOA, imaging, and respiratory solutions for clinical trials. Following its combination with Bioclinica, Clario operates as a scaled direct competitor across many of 4G Clinical's target use cases.

TypeBroad incumbent
Description

Oracle's Clinical One platform includes randomization and trial supply management capabilities integrated with EDC and CTMS. As a broad enterprise software incumbent, it competes with 4G Clinical especially for enterprise pharma deployments.

TypeBroad incumbent
Description

Veeva Vault RTSM extends Veeva's life sciences cloud platform into randomization and trial supply management. Veeva is a broad incumbent with strong relationships across enterprise pharma, creating bundling pressure for 4G Clinical.

TypeDirect peer
Description

YPrime provides eCOA, IRT/RTSM, and clinical trial technology with a focus on flexibility and patient-centric trial design. It serves the same biotech, CRO, and pharma customer segments as 4G Clinical with comparable RTSM functionality.

TypeDirect peer
Description

Almac offers IXRS/IRT technology alongside clinical trial supply services, providing end-to-end randomization and supply chain solutions. It overlaps directly with 4G Clinical's RTSM and 4C Supply offerings, often competing for the same sponsor programs.

TypeBroad incumbent
Description

IQVIA is a global CRO and clinical technology provider offering RTSM as part of its broader eClinical suite. As a broad incumbent with deep pharma relationships and CRO services, it competes with 4G Clinical especially in integrated RTSM-plus-CRO engagements.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

4G Clinical

Clinical Trial Software (RTSM)4gclinical.com

4G Clinical provides subscription-based randomization and trial supply management (RTSM) software, anchored by its Prancer RTSM® platform. It serves more than 100 biotech and pharma clients globally, including biotechs, CROs, and large pharmaceutical companies.

What 4G Clinical does

4G Clinical is a Wellesley, Massachusetts-based software company that provides randomization and trial supply management (RTSM) technology for clinical drug trials. Its core platform, Prancer RTSM®, unifies randomization, supply management, and study oversight in a single operational environment, keeping patient dosing, supply movement, and forecasting connected to real-time study activity. The product suite is complemented by 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial requirements, Ultima Rand® for randomization, and the Enterprise Prancer Integrations (EPI) framework for sponsor-level program governance. The company serves over 100 biotech and pharma clients globally, with horizontal segmentation across small and mid-size biotechs, contract research organizations (CROs), and large enterprise pharmaceutical companies.

4G Clinical operates a subscription-based enterprise SaaS model on multi-year contracts, with quote-based pricing and dedicated delivery specialists engaged from study kickoff through closeout. Go-to-market is direct enterprise sales supported by content marketing (blog, white papers, podcasts, webinars), industry events, and LinkedIn presence. The company holds filed/pending patents related to clinical trial randomization and supply management technology and markets itself on operational continuity, governed amendment pathways, and supply forecasting matched to protocol design.

The company was co-founded by David Kelleher (CEO) and Ed Tourtellotte (Board Director). In mid-2021, it closed a $230 million growth equity investment from Goldman Sachs Asset Management to fund global expansion, product development, and team growth. In August 2024, Dr. Ronan Brown was appointed as Chief Operating Officer, indicating continued organizational scaling. Headcount sits in the 251–500 range, and the company claims global delivery across multiple countries.

4G Clinical firmographics

Firmographics
Name
4G Clinical
Legal name
4G Clinical
Website
https://4gclinical.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
251–500 employees
Short description
4G Clinical provides subscription-based randomization and trial supply management (RTSM) software, anchored by its Prancer RTSM® platform. It serves more than 100 biotech and pharma clients globally, including biotechs, CROs, and large pharmaceutical companies.
Ownership category
akta.pro rank

4G Clinical industry classification

Industry
Product category
Clinical Trial Software (RTSM)
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAC
Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Randomization and trial supply management
  • Clinical trial software
  • RTSM solutions
  • Clinical supply forecasting
  • Trial supply optimization

Where 4G Clinical is headquartered

Location

Headquarters

HQ city
Wellesley
HQ country
United States
HQ region
North America

Offices1 record

Markets served

4G Clinical business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Subscription (RTSM): SaaS-based randomization and trial supply management software delivered as subscription service with dedicated delivery and specialist support throughout the study lifecycle.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise RTSM solutions with dedicated support

Distribution channels1 record

Marketing channels7 records

4G Clinical product offering

Product offering

Core offering

4G Clinical sells cloud-based Randomization and Trial Supply Management (RTSM) software, led by its Prancer RTSM® platform that unifies randomization, supply management, and study oversight for live clinical trial execution. The company complements this with 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial designs, EPI integration framework, and Ultima Rand® randomization technology, all delivered as a SaaS subscription with dedicated specialist teams supporting biotech, CRO, and pharma customers globally.

Product overview

4G Clinical delivers randomization and trial supply technology built for complex clinical trials. The core offering is Prancer RTSM®, which unifies randomization, supply management, and study oversight within a single operational environment. This is complemented by 4C Supply® for broader forecasting, scenario modelling, and long-range planning, as well as Prancer Lite® for studies with more streamlined requirements. Enterprise Prancer Integrations (EPI) provide a connectivity framework for scalable deployment across programs. The product suite supports over 100 biotech and pharma clients in global clinical trials.

Differentiator

Problem solved

Functional benefit

Brands

  • Prancer RTSM®: Flexible Randomization and Trial Supply Management solution that unifies randomization, supply management, and study oversight for more aligned trial execution.
  • Prancer Lite®
  • 4C Supply®
  • Ultima Rand®
  • Enterprise Prancer Integrations (EPI)

Products and services

  • Prancer RTSM® Cloud-based Randomization and Trial Supply Management (RTSM) platform that unifies randomization, supply, and forecasting for live clinical trial execution. It keeps patient dosing, supply movement, and oversight connected to real-time study activity for biotechs, CROs, and large pharma sponsors.
  • 4C Supply® Forecasting, scenario modeling, and supply oversight solution aligned to changing study demand, supporting min/max models through predictive and dynamic demand forecasting for clinical trial supply chains.
  • Prancer Lite® Lighter, simplified version of the Prancer RTSM platform for clinical studies with more streamlined randomization and supply requirements, typically used by smaller biotechs.
  • Ultima Rand® Supporting randomization technology that powers randomization capabilities within 4G Clinical's product ecosystem.

Quantifiable outcome

  • Supports clinical trials across multiple countries with global delivery experience
  • +1 more outcomes

Companies that use 4G Clinical

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

4G Clinical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

4G Clinical partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

4G Clinical competitors and assessment

Company assessment

Direct peers

  • Suvoda: Suvoda is a purpose-built IRT/RTSM specialist serving biotech and pharma sponsors with similar randomization, supply management, and eClinical workflows. It is the closest direct competitor to 4G Clinical's Prancer RTSM offering.
  • Endpoint Clinical: Endpoint Clinical (now part of the Clinical ink / broader portfolio) specializes in RTSM/IRT and interactive response technology for clinical trials. It targets similar biotech and pharma customers with comparable randomization and drug supply management functionality.
  • Signant Health: Signant Health provides RTSM alongside eCOA, eConsent, and patient engagement solutions for clinical trials. It directly competes with 4G Clinical in the randomization and trial supply management category, serving overlapping biotech and pharma customers.
  • Clario: Clario delivers RTSM/IRT, eCOA, imaging, and respiratory solutions for clinical trials. Following its combination with Bioclinica, Clario operates as a scaled direct competitor across many of 4G Clinical's target use cases.
  • YPrime: YPrime provides eCOA, IRT/RTSM, and clinical trial technology with a focus on flexibility and patient-centric trial design. It serves the same biotech, CRO, and pharma customer segments as 4G Clinical with comparable RTSM functionality.
  • Almac Group: Almac offers IXRS/IRT technology alongside clinical trial supply services, providing end-to-end randomization and supply chain solutions. It overlaps directly with 4G Clinical's RTSM and 4C Supply offerings, often competing for the same sponsor programs.

Broad incumbents

  • Medidata Solutions: Medidata (a Dassault Systèmes company) offers Rave RTSM as part of its industry-leading unified clinical trial platform spanning EDC, eCOA, and CTMS. It is a broad incumbent with deep enterprise pharma penetration and a major competitive force for 4G Clinical.
  • Oracle Health Sciences (Clinical One): Oracle's Clinical One platform includes randomization and trial supply management capabilities integrated with EDC and CTMS. As a broad enterprise software incumbent, it competes with 4G Clinical especially for enterprise pharma deployments.
  • Veeva Systems: Veeva Vault RTSM extends Veeva's life sciences cloud platform into randomization and trial supply management. Veeva is a broad incumbent with strong relationships across enterprise pharma, creating bundling pressure for 4G Clinical.
  • IQVIA: IQVIA is a global CRO and clinical technology provider offering RTSM as part of its broader eClinical suite. As a broad incumbent with deep pharma relationships and CRO services, it competes with 4G Clinical especially in integrated RTSM-plus-CRO engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

4G Clinical social profiles

Digital presence

4G Clinical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

4G Clinical leadership team

Management profile

Number of profiles

Profiles3 records

4G Clinical funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

4G Clinical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 4G Clinical

What does 4G Clinical do?

4G Clinical sells cloud-based Randomization and Trial Supply Management (RTSM) software, led by its Prancer RTSM® platform that unifies randomization, supply management, and study oversight for live clinical trial execution. The company complements this with 4C Supply® for forecasting and scenario modeling, Prancer Lite® for simpler trial designs, EPI integration framework, and Ultima Rand® randomization technology, all delivered as a SaaS subscription with dedicated specialist teams supporting biotech, CRO, and pharma customers globally.

Is 4G Clinical a public or private company?

4G Clinical is a private company. It is classified as venture growth investor backed and is currently operating.

When was 4G Clinical founded?

4G Clinical was founded in 2016. It employs 251 to 500 people.

Where is 4G Clinical based?

4G Clinical is headquartered in Wellesley, United States, in the North America region.

How does 4G Clinical make money?

One revenue line is on record: software Subscription (RTSM).

Who are 4G Clinical's main competitors?

Direct peers on record are Suvoda, Endpoint Clinical, Signant Health, Clario, YPrime and Almac Group. Broad incumbents are Medidata Solutions, Oracle Health Sciences (Clinical One), Veeva Systems and IQVIA.

Does 4G Clinical have an API?

No public API is recorded for 4G Clinical.

What industry is 4G Clinical in?

4G Clinical's product category is Clinical Trial Software (RTSM). Its primary akta.pro industry code is HLACAOAC, Randomization & Trial Supply Management (RTSM/IRT/IVRS/IWRS), with a secondary code of HLAGAEAK, Point-of-Care & Decentralized Trial Testing Services. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BitlyScoop: Goldman-backed 4G Clinical on the blockGoldman Sachs Asset Management is selling clinical trial software company 4G Clinical. The transaction reflects broader strategic interest in the sector as pharmaceutical companies increasingly rely on specialized software to manage complex drug studies.Comac-MedicalNavigating Clinical Trial Supply Management: Challenges, Trends & Smarter StrategiesThe article outlines the critical challenges and strategic solutions for clinical trial supply management, focusing on forecasting accuracy, cross-border regulatory compliance in Europe, and cold chain logistics. It highlights the operational complexities introduced by decentralized trials and emphasizes the adoption of technologies like Interactive Response Technology (IRT) and specialized platforms to ensure efficiency and regulatory adherence. The text identifies key industry players such as Suvoda, Almac, and 4G Clinical as providers of tailored supply chain solutions.CcrpsTop Clinical Trial Supply Chain Software Directory 2025This article presents a comprehensive directory of clinical trial supply chain management (SCM) software platforms designed to manage investigational product logistics, compliance, and real-time visibility for global trials. It details the critical role of these systems in preventing protocol deviations and ensuring GxP compliance through features like predictive resupply and temperature monitoring. The guide evaluates specific solutions including Suvoda, 4G Clinical, Almac Clinical Technologies, and MasterControl, while also promoting a related certification program.PR Newswire4G Clinical Appoints Global Life Sciences Leader Philippe Nore as New Chief Commercial Officer4G Clinical announced the appointment of Philippe Nore as its new Chief Commercial Officer. Nore brings over 25 years of life sciences experience, including leadership roles at Roche and Life Technologies, consulting work at Bain & Company and LEK Consulting, and most recently serving as Vice President MRD Pharma at Adaptive Biotechnologies. The company reported over 40% growth in live studies over the past year.PR Newswire4G Clinical Ranks No. 111 on the 2021 Inc. 5000, With Three-Year Revenue Growth of 3,699 Percent4G Clinical was ranked No. 111 on Inc. Magazine's 2021 Inc. 5000 list, recognizing it as one of America's fastest-growing private companies with a three-year revenue growth of 3,699 percent. This recognition follows a $230 million growth equity investment from Goldman Sachs Asset Management in June 2021 intended to fund global expansion and support product demand.PR NewswireDLA Piper advises 4G Clinical in US$230 million growth equity investment from Goldman Sachs Asset ManagementDLA Piper announced on July 21, 2021 that it represented 4G Clinical, a randomization and trial supply management firm, in a growth equity investment of over US$230 million from Goldman Sachs Asset Management. The funds will support global expansion and demand for its products, and 4G Clinical currently serves more than 100 biotech and pharma clients.PR Newswire4G Clinical annonce un investissement en capital de croissance de 230 millions de dollars soutenu par Goldman Sachs Asset Management4G Clinical, a randomization and trial supply management (RTSM) software company, announced it has secured a growth capital investment of over $230 million from Goldman Sachs Asset Management on June 29, 2021. The funding will support the company's continued global expansion and meet growing demand for its eClinical solutions, including the Prancer RTSM and 4C Supply platforms. Founded in 2015 and headquartered in Wellesley, Massachusetts, 4G Clinical reported over 100% growth in 2020 and currently supports clinical trials for more than 100 biotech and pharmaceutical clients worldwide.PR Newswire4G Clinical kündigt 230 Millionen US-Dollar Wachstumsbeteiligung an, die von Goldman Sachs Asset Management unterstützt wird4G Clinical announced it secured a growth equity investment of over $230 million from Goldman Sachs Asset Management on June 29, 2021. The capital will fund the company's further global expansion and support growing demand for its Randomization and Trial Supply Management (RTSM) products. Founded in 2015, the company grew over 100% in 2020 and currently supports clinical trials for more than 100 biotech and pharma customers worldwide.PR Newswire4G Clinical anuncia una inversión de capital de crecimiento de 230 millones de dólares4G Clinical, a randomization and trial supply management (RTSM) software company, announced it secured a growth capital investment of over $230 million from Goldman Sachs Asset Management. The funding will support the company's continued global expansion, meet growing demand for its products, and advance its mission to accelerate delivery of crucial medications to patients. Founded in 2015 and headquartered in Wellesley, Massachusetts, 4G Clinical experienced over 100% growth in 2020 and currently supports clinical trials for more than 100 biotech and pharmaceutical clients worldwide.